Platelet-rich plasma (PRP) therapy and hair transplant surgery are two of the most requested hair restoration treatments in 2026, but they solve fundamentally different problems. PRP uses concentrated growth factors from the patient’s own blood to stimulate miniaturized follicles that are still alive, while a hair transplant physically relocates DHT-resistant follicles to restore density in […]
Minoxidil is the most widely used FDA-approved topical treatment for androgenetic alopecia, available over the counter in liquid, foam, and oral micro-dose formulations. Clinical trials show that 5% topical minoxidil slows hair loss in approximately 85% of users and produces visible regrowth in 30-40% over 12 months. This guide covers the drug’s mechanism, clinical evidence, […]
Dutasteride is a dual 5-alpha reductase inhibitor that suppresses serum DHT by over 90 percent – roughly 30 percent more than finasteride, which blocks only the type II enzyme. Originally developed and FDA-approved for benign prostatic hyperplasia (BPH) under the brand name Avodart, dutasteride is not FDA-approved for androgenetic alopecia in the United States. Physicians […]
Hair transplant surgery and scalp micropigmentation are the two most durable solutions for hair loss, yet they solve the problem through entirely different mechanisms – one relocates real follicles, the other simulates them with pigment. Choosing between them depends on hair loss stage, donor supply, lifestyle preference, and budget. This comparison breaks down visual outcomes, […]
Microneedling is a collagen induction therapy that creates controlled micro-injuries in the scalp to stimulate hair follicle regeneration through wound-healing pathways and Wnt/beta-catenin signaling activation. Clinical evidence is strongest when microneedling is combined with minoxidil – the landmark Dhurat et al. (2013) trial demonstrated a 40% increase in hair count with the combination versus 11.4% […]
Hair transplant surgery and minoxidil represent the two most common treatments for androgenetic alopecia, yet they operate through fundamentally different biological mechanisms and deliver vastly different long-term outcomes. Minoxidil is a topical medication that slows hair loss and may regrow some thinning hair, but it requires lifelong daily application and loses effectiveness over time. A […]
Finasteride is the most clinically studied oral medication for androgenetic alopecia in men, with FDA approval since 1997 and over two decades of long-term safety and efficacy data. This 5-alpha reductase inhibitor blocks the conversion of testosterone into DHT – the androgen directly responsible for follicular miniaturization – and reduces scalp DHT levels by approximately […]
Hair loss shampoos are among the most purchased over-the-counter products for thinning hair, yet the vast majority lack meaningful clinical evidence for stopping or reversing androgenetic alopecia. The one clear exception is ketoconazole 2%, which has peer-reviewed data supporting its role as an adjunctive treatment alongside proven medications. This guide separates evidence-backed ingredients from marketing […]
Natural remedies for hair loss attract enormous consumer interest, but the clinical evidence behind most of them ranges from thin to nonexistent. Saw palmetto, rosemary oil, pumpkin seed oil, and marine protein supplements have at least some peer-reviewed data – though none approaches the efficacy of FDA-approved treatments like minoxidil or finasteride. This guide evaluates […]
Low-level laser therapy (LLLT) is an FDA-cleared, non-invasive treatment for androgenetic alopecia that uses red-light wavelengths to stimulate hair follicle activity through a process called photobiomodulation. Clinical evidence supports modest improvements in hair density – typically a 20–40 percent increase in hair count over 26 weeks – though results fall short of what minoxidil and […]
